BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 26, 2016
View Archived Issues
European Commission grants funding for development of new immunotherapy candidates
Read More
ISREC-EPFL presents novel Notch pathway inhibitor
Read More
ABBV-075 demonstrates robust antitumor activity in selected solid and hematological cancer models
Read More
OncoTherapy Science and Tella partner on neoantigen dendritic cells vaccine therapy
Read More
Mitobridge and The Salk Institute patent PPARdelta agonists
Read More
Merck & Co. discloses hypoxia-inducible factor prolyl hydroxylase inhibitors
Read More
Epigenetics Pharma reports silylated pyrimidine prodrugs
Read More
Glenmark Pharmaceuticals introduces inhibitors of S-nitrosoglutathione
Read More
Constellation Pharmaceuticals and Genentech jointly develop KDM5A inhibitors
Read More
F. Hoffmann-La Roche patent divulges CYP11B2 inhibitors
Read More
CD14 demonstrates potential as a biomarker of biliary stricture formation
Read More
FDA advisory committee votes on Sarepta's NDA for eteplirsen in DMD
Read More
Opdivo granted fifth FDA breakthrough therapy designation
Read More
U.S. launch of two PD-L1 companion diagnostics
Read More
Grant supports Chembio's development of oral fluid/saliva point-of-care diagnostic test for malaria
Read More
Recursion Pharmaceuticals and Sanofi Genzyme enter drug repurposing agreement
Read More
SIGA enrolls patients in final cohort of phase III trial of tecovirimat
Read More
Protalex reports early results from phase I/II PRTX-100 study in RA
Read More
Tesaro submits IND for TSR-022
Read More
Protea Biosciences in technology license agreement with Yale for malignant melanoma detection
Read More
FDA approves Cabometyx for advanced renal cell carcinoma
Read More
Novartis applies for approval of new indications for Ilaris in Japan
Read More
BARDA supports continued development of NewLink's Ebola vaccine candidate
Read More
Novel compound from Pfizer and iTeos targets indoleamine 2,3-dioxygenase-1 for cancer
Read More
Cocrystal Pharma begins phase Ia/Ib study of HCV drug candidate
Read More
FDA approves AbbVie's sNDA for Viekira Pak
Read More
Gilead Sciences's Descovy approved in E.U.
Read More